{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:58:47Z","timestamp":1779328727973,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2024CRI032"],"award-info":[{"award-number":["SHDC2024CRI032"]}],"id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["WKZX2024CX104102"],"award-info":[{"award-number":["WKZX2024CX104102"]}],"id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202140150"],"award-info":[{"award-number":["202140150"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-03-8"],"award-info":[{"award-number":["320.6750.2022-03-8"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750"],"award-info":[{"award-number":["320.6750"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bcp.2025.116919","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T23:29:51Z","timestamp":1743895791000},"page":"116919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["NUF2 activated by YY1 promotes prostate cancer malignancy via p38\/MAPK signaling axis and serves as a therapeutic target"],"prefix":"10.1016","volume":"237","author":[{"given":"Chengqi","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanxu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2025.116919_b0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.bcp.2025.116919_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors-a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.bcp.2025.116919_b0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 World Health Organization classification of tumors of the urinary system and male genital organs-part b: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bcp.2025.116919_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215927","article-title":"Prostate cancer treatment - China's perspective","volume":"550","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.bcp.2025.116919_b0025","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur. Urol. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116919_b0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.juro.2016.08.103","article-title":"Prostate specific antigen and prostate cancer in chinese men undergoing initial prostate biopsies compared with western cohorts","volume":"197","author":"Chen","year":"2017","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116919_b0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/bmb\/ldw050","article-title":"Cancer burden with ageing population in urban regions in China: projection on cancer registry data from World Health Organization","volume":"121","author":"Tsoi","year":"2017","journal-title":"Br. Med. Bull."},{"issue":"10","key":"10.1016\/j.bcp.2025.116919_b0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.trecan.2023.06.009","article-title":"Advances in the treatment of metastatic prostate cancer","volume":"9","author":"Gebrael","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bcp.2025.116919_b0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","article-title":"Treatment of advanced prostate cancer","volume":"70","author":"Teo","year":"2019","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.bcp.2025.116919_b0050","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1091\/mbc.e10-08-0671","article-title":"The NDC80 complex proteins Nuf2 and Hec1 make distinct contributions to kinetochore-microtubule attachment in mitosis","volume":"22","author":"Sundin","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.116919_b0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nrm.2015.5","article-title":"The molecular basis for centromere identity and function","volume":"17","author":"McKinley","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"40","key":"10.1016\/j.bcp.2025.116919_b0060","doi-asserted-by":"crossref","first-page":"16113","DOI":"10.1073\/pnas.1209615109","article-title":"The Ndc80 kinetochore complex directly modulates microtubule dynamics","volume":"109","author":"Umbreit","year":"2012","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.bcp.2025.116919_b0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.devcel.2017.04.013","article-title":"Dephosphorylation of the Ndc80 Tail stabilizes kinetochore-microtubule attachments via the Ska complex","volume":"41","author":"Cheerambathur","year":"2017","journal-title":"Dev. Cell"},{"issue":"8","key":"10.1016\/j.bcp.2025.116919_b0070","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrm4025","article-title":"Short- and long-term effects of chromosome mis-segregation and aneuploidy","volume":"16","author":"Santaguida","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.bcp.2025.116919_b0075","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.7150\/ijbs.70972","article-title":"NUF2 drives clear cell renal cell carcinoma by activating HMGA2 transcription through KDM2A-mediated H3K36me2 demethylation","volume":"18","author":"Lin","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2025.116919_b0080","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000003006","article-title":"Targeting NUF2 suppresses gastric cancer progression through G2\/M phase arrest and apoptosis induction","author":"Long","year":"2024","journal-title":"Chin Med. J. (Engl.)"},{"issue":"4","key":"10.1016\/j.bcp.2025.116919_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044226","article-title":"NUF2 promotes breast cancer development as a new tumor stem cell indicator","volume":"24","author":"Deng","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2025.116919_b0090","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ijc.32134","article-title":"NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection","volume":"145","author":"Wang","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2025.116919_b0100","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s12276-023-01010-3","article-title":"piRNA-1742 promotes renal cell carcinoma malignancy by regulating USP8 stability through binding to hnRNPU and thereby inhibiting MUC12 ubiquitination","volume":"55","author":"Zhang","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"21","key":"10.1016\/j.bcp.2025.116919_b0105","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"issue":"W1","key":"10.1016\/j.bcp.2025.116919_b0110","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.116919_b0115","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1093\/nar\/gkab252","article-title":"Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2\/4-PFKP during tumorigenesis of advanced prostate cancer","volume":"49","author":"Xu","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.116919_b0120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12931-021-01908-4","article-title":"TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension","volume":"22","author":"Cao","year":"2021","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.116919_b0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/med.10033","article-title":"Flavonoids: promising anticancer agents","volume":"23","author":"Ren","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2025.116919_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1057198","article-title":"NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes","volume":"12","author":"Leng","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116919_b0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13059-021-02322-1","article-title":"Mechanisms of enhancer action: the known and the unknown","volume":"22","author":"Panigrahi","year":"2021","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116919_b0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41588-021-01009-4","article-title":"Sequence determinants of human gene regulatory elements","volume":"54","author":"Sahu","year":"2022","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2025.116919_b0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrm3949","article-title":"The selection and function of cell type-specific enhancers","volume":"16","author":"Heinz","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.bcp.2025.116919_b0150","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41419-022-05363-x","article-title":"USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt\/mTOR signaling","volume":"13","author":"Huang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.116919_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.592164","article-title":"The why of YY1: mechanisms of transcriptional regulation by Yin Yang 1","volume":"8","author":"Verheul","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2025.116919_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133506","article-title":"Targeting transcription Factor YY1 for cancer treatment: current strategies and future directions","volume":"15","author":"Hosea","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bcp.2025.116919_b0165","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s12015-021-10151-9","article-title":"Roles played by YY1 in embryonic, adult and cancer stem cells","volume":"17","author":"Martinez-Ruiz","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2025.116919_b0170","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cell.2017.11.008","article-title":"YY1 Is a structural regulator of enhancer-promoter loops","volume":"171","author":"Weintraub","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2025.116919_b0175","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006020","article-title":"YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6","volume":"11","author":"Chen","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.116919_b0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-020-00949-4","article-title":"The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy","volume":"13","author":"Yuan","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2025.116919_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072346","article-title":"Understanding MAPK Signaling Pathways in Apoptosis","volume":"21","author":"Yue","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2025.116919_b0190","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.apsb.2018.01.008","article-title":"Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy","volume":"8","author":"Liu","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bcp.2025.116919_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010370","article-title":"The p38 MAPK components and modulators as biomarkers and molecular targets in cancer","volume":"23","author":"Garc\u00eda-Hern\u00e1ndez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2025.116919_b0200","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tips.2023.04.007","article-title":"Protein-protein interactions: developing small-molecule inhibitors\/stabilizers through covalent strategies","volume":"44","author":"Lucero","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.116919_b0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12967-024-04910-8","article-title":"DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2025.116919_b0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semcancer.2016.04.003","article-title":"Exploring the molecular targets of dietary flavonoid fisetin in cancer","volume":"40\u201341","author":"Syed","year":"2016","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116919_b0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2015.07.030","article-title":"Dietary flavonoid fisetin binds to \u03b2-tubulin and disrupts microtubule dynamics in prostate cancer cells","volume":"367","author":"Mukhtar","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.116919_b0220","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13046-022-02442-x","article-title":"Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells","volume":"41","author":"Khozooei","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2025.116919_b0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2022.01.013","article-title":"ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer","volume":"530","author":"Huang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2025.116919_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124528","article-title":"Fucoidan\/hyaluronic acid cross-linked zein nanoparticles loaded with fisetin as a novel targeted nanotherapy for oral cancer","volume":"241","author":"Moustafa","year":"2023","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225001819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225001819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:24:27Z","timestamp":1778631867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225001819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":45,"alternative-id":["S0006295225001819"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116919","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NUF2 activated by YY1 promotes prostate cancer malignancy via p38\/MAPK signaling axis and serves as a therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116919"}}